- Home
- MAV vs THRD Comparison
MAV vs THRD Comparison
Compare MAV & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAV
- THRD
- Stock Information
- Founded
- MAV 2003
- THRD 2019
- Country
- MAV United States
- THRD United States
- Employees
- MAV N/A
- THRD N/A
- Industry
- MAV Finance Companies
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- MAV Finance
- THRD Health Care
- Exchange
- MAV Nasdaq
- THRD Nasdaq
- Market Cap
- MAV 184.1M
- THRD 164.2M
- IPO Year
- MAV N/A
- THRD 2022
- Fundamental
- Price
- MAV $8.45
- THRD $5.16
- Analyst Decision
- MAV
- THRD Hold
- Analyst Count
- MAV 0
- THRD 3
- Target Price
- MAV N/A
- THRD $5.00
- AVG Volume (30 Days)
- MAV 66.2K
- THRD 1.1M
- Earning Date
- MAV 01-01-0001
- THRD 05-19-2025
- Dividend Yield
- MAV 4.30%
- THRD N/A
- EPS Growth
- MAV N/A
- THRD N/A
- EPS
- MAV N/A
- THRD N/A
- Revenue
- MAV N/A
- THRD N/A
- Revenue This Year
- MAV N/A
- THRD N/A
- Revenue Next Year
- MAV N/A
- THRD N/A
- P/E Ratio
- MAV N/A
- THRD N/A
- Revenue Growth
- MAV N/A
- THRD N/A
- 52 Week Low
- MAV $6.37
- THRD $3.18
- 52 Week High
- MAV $8.34
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- MAV 56.06
- THRD 77.22
- Support Level
- MAV $8.11
- THRD $5.11
- Resistance Level
- MAV $7.91
- THRD $5.25
- Average True Range (ATR)
- MAV 0.09
- THRD 0.05
- MACD
- MAV 0.05
- THRD -0.04
- Stochastic Oscillator
- MAV 79.59
- THRD 38.41
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax and as a secondary objective to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.